Proteomic identification of a monoclonal antibody recognizing caveolin-1 in hepatocellular carcinoma with metastatic potential

Protein and Peptide Letters

Volumn 16, Issue 5, 2009, Pages 479-485

  Hu, Mei Yu ^a   Lam, Chi Tat ^a   Liu, Kang Da ^b   Xu, Zhi ^a   Fatima, Sarwat ^a   Su, Yvonne C F ^a   Tsang, Felice ^a   Chen, Jie ^b   Pang, Jin Zhong ^b   Qin, Lun Xiu ^b   Luk, J M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

Author keywords

Caveolin 1; Hepatocellular carcinoma; Metastasis; Monoclonal antibody

Indexed keywords

CAVEOLIN 1; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; CHEMISTRY; GENE EXPRESSION REGULATION; HUMAN; IMMUNOLOGY; LIVER CELL CARCINOMA; METASTASIS; MOLECULAR GENETICS; PATHOLOGY; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; CARCINOMA, HEPATOCELLULAR; CAVEOLIN 1; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 67649378832     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788167743     Document Type: Article

References (29)

1. But, D. Y.; Lai, C. L.; Yuen, M. F. Natural history of hepatitis- related hepatocellular carcinoma. World J. Gastroenterol., 2008, 14(11), 1652-6.
2. Feitelson, M. A.; Sun, B.; Satiroglu Tufan, N. L.; Liu, J.; Pan, J.; Lian, Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene, 2002, 21(16), 2593-604.
3. Kemp, W.; Pianko, S.; Nguyen, S.; Bailey, M. J.; Roberts, S. K. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J. Gastroenterol. Hepatol., 2005, 20(6), 873-81.
4. Herold, C.; Reck, T.; Fischler, P.; Ott, R.; Radespiel-Troeger, M.;Ganslmayer, M.; Hohenberger, W.; Hahn, E. G.; Schuppan, D. Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre. Liver, 2002, 22(1), 23-8.
5. Avila, M. A.; Berasain, C.; Sangro, B.; Prieto, J. New therapies for hepatocellular carcinoma. Oncogene, 2006, 25(27), 3866-84.
6. Yi, X.; Luk, J. M.; Lee, N. P.; Peng, J.; Leng, X.; Guan, X. Y.; Lau, G. K.; Beretta, L.; Fan, S. T. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol. Cell. Proteomics, 2008, 7(2), 315-25.
7. Yang, J. M.; Peng, Z. H.; Si, S. H.; Liu, W. W.; Luo, Y. H.; Ye, Z.Y. KAI1 gene suppresses invasion and metastasis of hepatocellu- lar carcinoma MHCC97-H cells in vitro and in animal models. Liver Int., 2008, 28(1), 132-9.
8. Yuan, R. H.; Jeng, Y. M.; Chen, H. L.; Lai, P. L.; Pan, H. W.; Hsieh, F. J.; Lin, C. Y.; Lee, P. H.; Hsu, H. C. Stathmin overex-pression cooperates with p53 mutation and osteopontin overexpres- sion, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma. J. Pathol., 2006, 209(4), 549-58.
9. Yamashita, T.; Forgues, M.; Wang, W.; Kim, J. W.; Ye, Q.; Jia, H.; Budhu, A.; Zanetti, K. A.; Chen, Y.; Qin, L. X.; Tang, Z. Y.; Wang, X. W. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res., 2008, 68(5), 1451-61.
10. Campbell, L.; Jasani, B.; Edwards, K.; Gumbleton, M.; Griffiths, D. F. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. Br. J. Cancer, 2008, 98(5), 931-40.
11. Fra, A. M.; Mastroianni, N.; Mancini, M.; Pasqualetto, E.; Sitia, R. Human caveolin-1 and caveolin-2 are closely linked genes colocal- ized with WI-5336 in a region of 7q31 frequently deleted in tumors. Genomics, 1999, 56(3), 355-6.
12. Yerian, L. M.; Anders, R. A.; Tretiakova, M.; Hart, J. Caveolin and thrombospondin expression during hepatocellular carcinogenesis. Am. J. Surg. Pathol., 2004, 28(3), 357-64.
13. Fang, Y.; Hu, M.; Liu, K. Kinetics of tumorigenic vascular endo- thelial growth factor signalling and its significance in human hepa- tocellular carcinoma cells. Biomed. Pharmacother., 2001, 55(2),102-10.
14. Tian, J.; Tang, Z.; Ye, S. [Establishment of a human hepatocellular carcinoma (HCC) cell line with high metastatic potential (MHCC97) and its biological characteristics]. Zhonghua Zhong LiuZa Zhi, 1998, 20(6), 405-7.
15. Luk, J. M.; Chan, K. H.; Tsang, R. S.; Ng, M. H. Characterisation and application of a murine monoclonal antibody specific for theserogroup C2 Salmonella. J. Med. Microbiol., 1988, 26(2), 115-9.
16. Luk, J. M.; Lind, S. M.; Tsang, R. S.; Lindberg, A. A. Epitope mapping of four monoclonal antibodies recognizing the hexose core domain of Salmonella lipopolysaccharide. J. Biol. Chem., 1991, 266(34), 23215-25.
17. Luk, J. M.; Su, Y. C.; Lam, S. C.; Lee, C. K.; Hu, M. Y.; He, Q. Y.;Lau, G. K.; Wong, F. W.; Fan, S. T. Proteomic identification of Ku70/Ku80 autoantigen recognized by monoclonal antibody against hepatocellular carcinoma. Proteomics, 2005, 5(7), 1980-6.
18. Luk, J. M.; Lam, C. T.; Siu, A. F.; Lam, B. Y.; Ng, I. O.; Hu, M.Y.; Che, C. M.; Fan, S. T. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values. Proteomics, 2006, 6(3), 1049-57.
19. Scherer, P. E.; Tang, Z.; Chun, M.; Sargiacomo, M.; Lodish, H. F.; Lisanti, M. P. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem., 1995, 270(27), 16395-401.
20. Fujimoto, T.; Kogo, H.; Nomura, R.; Une, T. Isoforms of caveolin- 1 and caveolar structure. J. Cell Sci., 2000, 113 Pt 19(3509-17).
21. Lee, S. W.; Reimer, C. L.; Oh, P.; Campbell, D. B.; Schnitzer, J. E. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene, 1998, 16(11), 1391-7.
22. Karam, J. A.; Lotan, Y.; Roehrborn, C. G.; Ashfaq, R.;Karakiewicz, P. I.; Shariat, S. F. Caveolin-1 overexpression is as-sociated with aggressive prostate cancer recurrence. Prostate, 2007, 67(6), 614-22.
23. Kato, K.; Hida, Y.; Miyamoto, M.; Hashida, H.; Shinohara, T.; Itoh, T.; Okushiba, S.; Kondo, S.; Katoh, H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer, 2002, 94(4), 929-33.
24. Williams, T. M.; Lisanti, M. P. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am. J. Physiol. Cell Physiol., 2005, 288(3), C494-506.
25. Lee, H.; Volonte, D.; Galbiati, F.; Iyengar, P.; Lublin, D. M.;Bregman, D. B.; Wilson, M. T.; Campos-Gonzalez, R.; Bouzahzah,B.; Pestell, R. G.; Scherer, P. E.; Lisanti, M. P. Constitutive andgrowth factor-regulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol. Endocrinol., 2000, 74(11), 1750-75.
26. [ 26]Schlegel, A.; Arvan, P.; Lisanti, M. P. Caveolin-1 binding to endo- plasmic reticulum membranes and entry into the regulated secre-tory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. J. Biol. Chem., 2001, 276(6), 4398-408.
27. Hayashi, K.; Matsuda, S.; Machida, K.; Yamamoto, T.; Fukuda, Y.;Nimura, Y.; Hayakawa, T.; Hamaguchi, M. Invasion activating caveolin-1 mutation in human scirrhous breast cancers. Cancer Res., 2001, 67(6), 2361-4.
28. Yokomori, H.; Oda, M.; Wakabayashi, G.; Kitajima, M.; Yoshi- mura, K.; Nomura, M.; Hibi, T. High expressions of caveolins on the proliferating bile ductules in primary biliary cirrhosis. World J. Gastroenterol., 2005, 77(24), 3710-3.
29. Anders, R. A.; Yerian, L. M.; Tretiakova, M.; Davison, J. M.; Quigg, R. J.; Domer, P. H.; Hoberg, J.; Hart, J. cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis. Am. J. Pathol., 2003, 762(3),991-1000.